3,4,5,6-Tetrahydroxyxanthone Protects Against Myocardial Ischemia-Reperfusion Injury in Rats

Authors: Zhong Dai1; De-Jian Jiang1; Gao-Yun Hu2; Yan-Hua Du1; Jing Yu1; Chang-Ping Hu1; Dan Luo1; Yuan-Jian Li3

Source: Cardiovascular Drugs and Therapy, Volume 18, Number 4, July 2004 , pp. 279-288(10)

Publisher: Springer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

In the present study, we tested the protective effect of 3,4,5,6-tetrahydroxyxanthone, a synthetic xanthone derivative, on myocardial ischemia-reperfusion injury in rats. Ischemia-reperfusion injury was induced by 30 min of global ischemia and 30 min of reperfusion in isolated rat hearts or 30 min coronary artery occlusion and 120 min reperfusion in vivo, respectively. Heart rate, coronary flow (CF), left ventricular pressure (LVP), and its first derivative (±dp/dtmax) were recorded, and the activity of creatine kinase in coronary effluent and tumor necrosis factor-alpha (TNF-alpha) content in myocardial tissues were measured in vitro. The activity of serum creatine kinase, the level of TNF-alpha and interleukin-6 (IL-6), and myocardial infarct size were measured in vivo. 3,4,5,6-tetrahydroxyxanthone (30, 100 or 300 muM) caused a significant improvement of cardiac function (LVP and ±dp/dtmax) and a decrease in the release of creatine kinase in coronary effluent as well as the level of TNF-alpha in myocardial tissues in vitro. 3,4,5,6-tetrahydroxyxanthone (0.5 or 1.0 mg/kg, i.v.) also markedly decreased infarct size and the release of creatine kinase and TNF-alpha, and increased serum IL-6 level in vivo. These results suggest that 3,4,5,6-tetrahydroxyxanthone possesses a protective effect on myocardial ischemia-reperfusion injury, and that the protective effects of 3,4,5,6-tetrahydroxyxanthone may be related to inhibition of TNF-alpha production and stimulation of IL-6 generation by inhibition of ROS production.

Keywords: 3,4,5,6-tetrahydroxyxanthone; ischemia-reperf- usion; heart; tumor necrosis factor-alpha; interleukin-6

Document Type: Research article

DOI: 10.1023/B:CARD.0000041247.95545.55

Affiliations: 1: Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China 2: Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China 3: Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China., Email: yuan_jianli@yahoo.com

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A